Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Κατάταξη σε μετοχές #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Τιμή μετοχής
$9.60
Τελευταίος συγχρονισμός: 2025-05-21
Κεφαλαιοποίηση
$1.08B
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο OptiNose, Inc. (OPTN)

Κατηγορία

EPS για OptiNose, Inc. (OPTN)
EPS στις March 2025 TTM: $-2.67
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της OptiNose, Inc., το τρέχον EPS της εταιρείας (TTM) είναι $-2.67. Στο τέλος του 2023, η εταιρεία είχε EPS $-0.32, μείωση σε σύγκριση με το EPS του 2022 που ήταν $-13.05.
Ιστορικό EPS της OptiNose, Inc. από 2015 έως 2026
EPS στο τέλος κάθε έτους
Έτος EPS Αλλαγή
2026 (TTM) $-2.67 25.94%
2024 $-2.12 562.50%
2023 $-0.32 -97.55%
2022 $-13.05 806.25%
2021 $-1.44 -29.41%
2020 $-2.04 -21.54%
2019 $-2.60 -2.99%
2018 $-2.68 83.56%
2017 $-1.46 -505.56%
2016 $0.36 -108.39%
2015 $-4.29 0.00%
EPS για παρόμοιες εταιρείες ή ανταγωνιστές